Biology of multiple myeloma--host-tumour interactions and immune regulation of disease activity

CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre Origin.

Leukemia & lymphoma·2016

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.

Blood cancer journal·2013

Leukaemias into the 21st century. Part 2: the chronic leukaemias.

Internal medicine journal·2013

Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research setting.

International journal of laboratory hematology·2013

Leukaemias into the 21st century: part 1: the acute leukaemias.

Internal medicine journal·2012

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.

Internal medicine journal·2009

Adjusted Indirect Comparison Between Epcoritamab-R2 and Tafasitamab-R2 in Relapse/Refractory Follicular Lymphoma.

Hematological oncology·2026

Teclistamab Induced a Profound Hematologic Response in Light Chain Deposition Disease With Probable Cardiac Involvement.

Hematological oncology·2026

Non-Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis.

Hematological oncology·2026

NFS1 as a Metabolic Vulnerability in Acute Myeloid Leukemia Through Iron Dysregulation and STAT1/IFIT2-Associated Signaling.

Hematological oncology·2026

Clinical Characteristics of Coexistent Chronic Myeloid Leukemia and BCR::ABL1 Negative Myeloproliferative Neoplasms: A Retrospective Study.

Hematological oncology·2026

Real-World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis.

Hematological oncology·2026

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

International journal of molecular sciences·2026

Hypothyroidism and Thyroxine-Induced Hyperthyroidism Differentially Affect Cathepsins, Mct8, and Thyroid Tissue Architecture in Male Mice.

International journal of molecular sciences·2026

To Be or Not to Be-Thymocyte Survival and Death in the Thymic Medulla.

International journal of molecular sciences·2026

Macrophage Density Patterns in Uterine Leiomyomas Across Patient Age Groups: Evaluation of Separately Quantified CD68-Positive and CD163-Positive Cells.

Current issues in molecular biology·2026

Transcriptomic Convergence Reveals Tumour-Specific Stromal Remodelling in Immune-Enriched Papillary Thyroid Carcinoma.

Cancers·2026

MRI-Based Prediction of Immunotherapy Response in Breast Cancer: A Systematic Review.

Cancers·2026

Related Experiment Videos

Biology of multiple myeloma--host-tumour interactions and immune regulation of disease activity

Related Concept Videos

CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre Origin.

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.

Leukaemias into the 21st century. Part 2: the chronic leukaemias.

Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research setting.

Leukaemias into the 21st century: part 1: the acute leukaemias.

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.

Adjusted Indirect Comparison Between Epcoritamab-R2 and Tafasitamab-R2 in Relapse/Refractory Follicular Lymphoma.

Teclistamab Induced a Profound Hematologic Response in Light Chain Deposition Disease With Probable Cardiac Involvement.

Non-Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis.

NFS1 as a Metabolic Vulnerability in Acute Myeloid Leukemia Through Iron Dysregulation and STAT1/IFIT2-Associated Signaling.

Clinical Characteristics of Coexistent Chronic Myeloid Leukemia and BCR::ABL1 Negative Myeloproliferative Neoplasms: A Retrospective Study.

Real-World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis.

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

Hypothyroidism and Thyroxine-Induced Hyperthyroidism Differentially Affect Cathepsins, Mct8, and Thyroid Tissue Architecture in Male Mice.

To Be or Not to Be-Thymocyte Survival and Death in the Thymic Medulla.

Macrophage Density Patterns in Uterine Leiomyomas Across Patient Age Groups: Evaluation of Separately Quantified CD68-Positive and CD163-Positive Cells.

Transcriptomic Convergence Reveals Tumour-Specific Stromal Remodelling in Immune-Enriched Papillary Thyroid Carcinoma.

MRI-Based Prediction of Immunotherapy Response in Breast Cancer: A Systematic Review.

Related Experiment Videos

Biology of multiple myeloma--host-tumour interactions and immune regulation of disease activity

Related Concept Videos

Related Articles